Concizumab (Anti-TFPI)

製品コード：A2337        

印刷

Concizumab (Anti-TFPI) is an anti-TFPI monoclonal antibody (IgG4 type) that binds to the Kunitz-type protease inhibitor (KPI) 2 structural domain of TFPI, thereby blocking the interaction of this structural domain with the FXa active site. MW : 145.5 KD.

製品説明

CAS No. 1312299-39-0
Formulation 100mMPro-Ac,20mMArg-Ac，pH5.0
Isotype Human IgG4SP
Source CHO
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.
Shipping Shipped under low temperature conditions

人間や獣医の診断であるか治療的な使用のためにでない。